NCT00559156View on ClinicalTrials.gov

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Head and Neck Cancer
Interventions
DIETARY_SUPPLEMENT

arginine/omega-3 fatty acids/nucleotides oral supplement

DRUG

cisplatin

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT00559156 - Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy | Biotech Hunter | Biotech Hunter